VTR
70
3
KLAC
70
5
NVDA
49
3
EL
61
3
PEG
46
2
ALL
54
-6
ADSK
62
6
MAC
67
2
HUM
42
8
AON
67
2
AA
76
3
WM
57
-2
WFC
69
-5
RSG
45
-3
AN
43
-6
LMT
55
-4
AVY
54
-7
FDX
61
11
AIV
39
-2
PWR
53
2
VTR
70
3
KLAC
70
5
NVDA
49
3
EL
61
3
PEG
46
2
ALL
54
-6
ADSK
62
6
MAC
67
2
HUM
42
8
AON
67
2
AA
76
3
WM
57
-2
WFC
69
-5
RSG
45
-3
AN
43
-6
LMT
55
-4
AVY
54
-7
FDX
61
11
AIV
39
-2
PWR
53
2
Financhill
Back

Nuveen Credit Strategies Income Fund Vs. Amphastar Pharmaceuticals, Inc. Industry Stock Comparison

Buy
62

JQC
Nuveen Credit Strategies Income Fund

Last Price:
$5.01
Seasonality Move:
0.94%
Sell
41

AMPH
Amphastar Pharmaceuticals, Inc.

Last Price:
$26.58
Seasonality Move:
-3.24%
Buy
62
Nuveen Credit Strategies Income Fund (JQC) is a Buy

Is Nuveen Credit Strategies Income Fund a Buy, Sell or Hold?

  • The current Nuveen Credit Strategies Income Fund [JQC] share price is $5.02. The Score for JQC is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
  • JQC is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
41
Amphastar Pharmaceuticals, Inc. (AMPH) is a Sell

Is Amphastar Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current Amphastar Pharmaceuticals, Inc. [AMPH] share price is $26.50. The Score for AMPH is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • AMPH is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

JQC Stock Price Chart

What is Nuveen Credit Strategies Income Fund's stock price today?

  • The Nuveen Credit Strategies Income Fund share price today is $5.02
    The current trend is relatively stagnant and JQC is experiencing buying pressure, which is a positive indicator for future bullish movement.

AMPH Stock Price Chart

What is Amphastar Pharmaceuticals, Inc.'s stock price today?

  • The Amphastar Pharmaceuticals, Inc. share price today is $26.50
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AMPH is experiencing buying pressure, which is a positive indicator for future bullish movement.

JQC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 44.65 Sell
Chaikin Money Flow: 1323073 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4.99 - 5.09) Sell
Bollinger Bands (100): (5.05 - 5.45) Sell

AMPH Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.01 Buy
Relative Strength Index (14 RSI): 52.53 Buy
Chaikin Money Flow: 223954 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (25.62 - 27.12) Buy
Bollinger Bands (100): (23.99 - 28.89) Buy

JQC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 5.03 Sell
20-day SMA: 5.04 Sell
50-day SMA: 5.07 Sell
200-day SMA: 5.28 Sell
8-day EMA: 5.02 Sell
20-day EMA: 5.04 Sell
50-day EMA: 5.1 Sell
200-day EMA: 5.29 Sell

AMPH Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 25.88 Buy
20-day SMA: 26.47 Buy
50-day SMA: 25.5 Buy
200-day SMA: 25.63 Buy
8-day EMA: 26.12 Buy
20-day EMA: 26.19 Buy
50-day EMA: 26.08 Buy
200-day EMA: 27.9 Sell

Nuveen Credit Strategies Income Fund Earnings Growth & JQC Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Amphastar Pharmaceuticals, Inc. Earnings Growth & AMPH Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.49 per share, and an increase next year of $0.20 per share.

Nuveen Credit Strategies Income Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Amphastar Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):